TRACON Pharmaceuticals Garners $36,000,000 New Round

  • Feed Type
  • Date
    1/30/2015
  • Company Name
    TRACON Pharmaceuticals
  • Mailing Address
    8910 University Center Dr. San Diego, CA 92122 USA
  • Company Description
    TRACON Pharmaceuticals, Inc. (NASDAQ: TCON) is a biotechnology company developing next-generation targeted therapies for cancer and related diseases. We are addressing unmet needs in this arena with product candidates that focus on cellular targets specifically implicated in cancer growth and angiogenesis.
  • Website
    http://www.traconpharma.com
  • Transaction Type
    IPO
  • Transaction Amount
    $36,000,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes are on file with company statements at the SEC.
  • M&A Terms

Trending on Xconomy